The Dow Chemical Company

U.S.A

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Tablet

Grade :

Brand Name : WALOCEL™ C

Application : Coating Systems & Additives, Rheology Modifiers

Excipient Details : Tablet Coating, Rheology Modifier

Pharmacopoeia Ref :

Technical Specs :

Ingredient(s) : Carboxymethyl cellulose sodium

Dosage Form : Tablet

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Carboxymethyl cellulose sodium

Dosage Form : Tablet

Category : Coating Systems & Additives, Rheology Modifiers

Brand : WALOCEL™ C

Applications : Tablet Coating, Rheology Modifier

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

Looking for Pharmaceutical Excipients offered by The Dow Chemical Company? Find Tox21_300583 to address your drug delivery challenges on PharmaCompass.

Tox21_300583

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

14 USDMF

1 CEP/COS

2 EU WC

4 NDC API

1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers

47 FDA Orange Book

18 Europe

21 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

13 SPI Pharma

9 DKSH

7 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

2 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

12 Kerry

1 Kima Chemical

3 Lonza Capsugel

13 Microlex e.U

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

1 Qualicaps

15 Roquette

1 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

27 Direct Compression

24 Thickeners and Stabilizers

16 Taste Masking

15 Disintegrants & Superdisintegrants

15 Granulation

14 Coating Systems & Additives

13 Co-Processed Excipients

13 Lubricants & Glidants

11 Chewable & Orodispersible Aids

8 Empty Capsules

6 Film Formers & Plasticizers

6 Controlled & Modified Release

6 Parenteral

5 Solubilizers

4 Topical

4 Rheology Modifiers

3 Coloring Agents

2 Emulsifying Agents

1 API Stability Enhancers

1 Surfactant & Foaming Agents

DIGITAL CONTENT

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons